AdipoLABs Opens Regional Office, Inks Two MoUs With UoC To Advance Healthcare Innovation

PETALING JAYA, Nov 28 (Bernama) -- AdipoLABs Co Ltd and Red & Blue Co Ltd from Korea, together with their Malaysian subsidiary AdipoLABs Healthcare (M) Sdn Bhd, today officially opened the new AdipoLABs regional office for the Asia-Pacific region, marking a strategic expansion to strengthen its leadership in non-invasive healthcare and build a robust MedTech ecosystem in Malaysia and across ASEAN.

AdipoLABs Co Ltd chief executive officer Han Sung-ho said the company’s presence is expected to drive knowledge transfer, foster research and development (R&D) collaboration, provide industry-standard training and enhance the country’s preventive healthcare capabilities.

“By uniting our hyperthermia technology with local expertise and academic rigour, we’ll expedite the adoption of advanced solutions and improve patient outcomes worldwide. We envision this collaboration as a blueprint for international healthcare partnerships,” he said in his speech at the opening ceremony here today. 

To commemorate the opening, the company also signed two Memoranda of Understanding (MoUs) with the University of Cyberjaya (UoC), formalising a partnership to advance healthcare innovation, clinical research and talent development.

A key component of the first MoU is a comprehensive internship programme with UoC’s physiotherapy programmes under the Faculty of Health, offering six-month placements and potential job opportunities to give students real-world experience.

Students from the Faculty of Health will gain hands-on experience with AdipoLABs’ Pain Bot device, enhancing their skills in pain detection and treatment, while students from the School of Biomedical Engineering will support AdipoLABs’ technical operations, strengthening after-sales service and device maintenance.

As part of the partnership, AdipoLABs will also implement a strategic client engagement initiative, where interns may be placed at client facilities to demonstrate device effectiveness and provide on-site support.

Meanwhile, AdipoLABs Healthcare (M) Sdn Bhd director Dr Isaac R. Joseph said the initiative reflects the company’s commitment to nurturing talent, creating pathways to permanent employment and ensuring the optimal use of its technology.

He said the collaboration also extends to clinical research, with UoC professors and students conducting studies on various AdipoLABs medical devices to generate evidence-based insights that will be published in reputable journals, providing scientific validation for the technologies.

“We’re thrilled to collaborate with the UoC to cultivate local talent and drive Malaysian healthcare innovation. This partnership offers UoC students invaluable hands-on experience with technologies like Pain Bot.

“It also expands our clinical research, enhancing pain management solutions for patients across Malaysia and ASEAN. We are dedicated to empowering future healthcare leaders,” he said.

In a parallel effort to advance physiotherapy education, AdipoLABs Malaysia, Red & Blue Co Ltd and UoC signed a second MoU centred on knowledge transfer and medical device donation.

Under this agreement, AdipoLABs Malaysia will donate a Pain Bot unit to UoC, enabling students to access cutting-edge pain detection and treatment technology and strengthening their knowledge in musculoskeletal pain management.

AdipoLABs, a Ministry of Health (MOH)-registered medical device establishment under the Medical Device Authority (MDA), anchors this collaboration with proven regulatory credibility and a strong commitment to quality and innovation.

UoC vice-chancellor Dr David Whitford said their certified standing reinforces UoC’s ambition to accelerate evidence-based research and industry-ready healthcare solutions.

“AdipoLABs’ partnership with the UoC is more than a collaboration; it is a direct investment in the next generation of healthcare professionals.

“With the introduction of advanced rehabilitative technologies, our students gain access to international-standard tools and real-world innovation that will shape their confidence, competence and future careers,“ he said.

Further strengthening the collaboration, Prof Dr Yoo Seung-mo from South Korea, the inventor of the Pain Bot, will serve as an adjunct professor at UoC and will provide on-site training and ongoing remote mentorship, ensuring students receive expert guidance in utilising the Pain Bot technology and applying advanced pain detection and treatment techniques.

Together, UoC and AdipoLABs are positioned to drive forward Malaysia’s healthcare innovation agenda with greater confidence and impact. 

-- BERNAMA